Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

Completed · Phase 3

Conditions studied: Hypertension

In brief

The purpose of this study is to evaluate the effects of nebivolol on blood pressure and heart rate in African American patients with hypertension.

Key facts

Study ID

NCT00145210

Run by

Mylan Bertek Pharmaceuticals

People needed

630

Starts

2005-04-01

Expected to finish

2007-09-01

Last updated by the study team

2008-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• African Americans with stage 1-2 hypertension

You may not qualify if…

• Recent myocardial infarction or stroke
• Contraindications to beta-blocker therapy or stopping prior antihypertensive therapy

Where it is running

• Mylan Pharmaceuticals Inc. — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.